Florence Healthcare Welcomes Tarek Sherif to Board of Directors

Rhea-AI Summary

Tarek Sherif, co-founder of Medidata and Life Sciences & Healthcare Sector Board Chairman for Dassault Systemes, joins the board of directors at Florence. With over 20 years of experience, including leading Medidata to an IPO and acquiring it for $5.8B, Sherif aims to enhance Florence's position in clinical research. The company, serving over 10,000 trial sites in 44 countries, recently raised $80M in a Series C funding round to improve trial site efficiencies and connectivity in clinical development.

Positive

• Tarek Sherif's appointment brings significant experience in life sciences and technology.
• Florence's platform supports over 10,000 research sites, enhancing its market presence.
• The company recently raised $80M in Series C funding to expand operations.

Negative

• None.

Co-founder of Medidata and Life Sciences & Healthcare Sector Board Chairman for Dassault Systemes to help expand Florence’s network presence in life science research

ATLANTA--(BUSINESS WIRE)--

Life sciences technology veteran Tarek Sherif joins the board of directors of Florence, the industry leader in remote connectivity in clinical research. Over a 20-year period, Sherif led Medidata from a startup through an IPO, to become the market leader in cloud-based solutions in the life sciences industry. Sherif will help guide Florence’s growth in that same industry. Dassault Systemes acquired Medidata for $5.8B in 2019.

“Our goal is to advance cures by helping more trial site research teams than any other company,” says Ryan Jones, CEO of Florence. “In the first chapter of our story, we made clinical trial sites more efficient, and today 10,000 of them across 44 countries use Florence. We now have a unique opportunity in our next chapter to connect that site community to the full clinical development lifecycle. With Sherif, we've added the world's foremost expert on serving research at scale to meet this challenge."

Florence’s new phase of growth began last year by serving as a foundational technology in three of the five largest vaccine studies, including the Pfizer phase 2/3 COVID-19 vaccine study. Building on this success, the company expanded its goal to improving trial site efficiency across the entire clinical research process.

“Florence recognizes the importance of placing sites and patients at the center of research,” said Sherif. “The company’s site-first perspective solves a last-mile problem historically overlooked by technology providers in this market. I’m looking forward to working with the exceptional team at Florence to make the world a better place by deploying the best technology where the work of research gets done — the trial site.”

Sherif joins a strong group of industry veterans on the Florence Board on the heels of its recent $80M Series C round including:

• Carla Balch, Spesana, Inc.
• Jeff Muir, Fulcrum Equity Partners
• Jon Rosenbaum, Insight Partners
• Peter Sobiloff, Insight Partners
• Ryan Jones, Florence Healthcare
• Andres Garcia, Florence Healthcare

POWERED BY FLORENCE

Florence’s clinical trial software helps more than 10,000 research sites in 44 countries manage their documents, data, and workflows. The Florence platform also provides remote access so sponsors and CROs can collaborate with their sites around the world. Florence users now perform 3 million remote monitoring activities each month. To learn more, visit florencehc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005055/en/

Lauren Watt

Trevelino/Keller

404.214.0722 x116

lwatt@trevelinokeller.com

Source: Florence

FAQ

Who is Tarek Sherif and what is his connection to DASTY?

Tarek Sherif is the co-founder of Medidata and a board member of Florence, which is affiliated with Dassault Systemes (DASTY).

What impact will Tarek Sherif have on Florence?

Sherif's extensive experience in life sciences technology is expected to guide Florence's growth in clinical research.

How many trial sites does Florence currently support?

Florence supports over 10,000 research sites across 44 countries.

What recent funding did Florence secure?

Florence raised $80M in a Series C funding round to enhance trial site efficiency and connectivity.

What is the significance of Medidata's acquisition by Dassault Systemes?

Medidata was acquired by Dassault Systemes for $5.8B, enhancing its capabilities in cloud-based life sciences solutions.